Sotera Health (SHC) Cash & Equivalents (2020 - 2026)

Sotera Health's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $314.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 3.21% year-over-year to $314.1 million; the TTM figure through Mar 2026 stood at $314.1 million (up 3.21% YoY), while the FY2025 annual figure was $344.6 million, up 24.3% from the prior year.
• Cash & Equivalents was $314.1 million for Q1 2026 at Sotera Health, down from $344.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $647.9 million in Q1 2023 to a low of $121.4 million in Q1 2022.
• Historically, Cash & Equivalents has averaged $291.7 million across 5 years, with a median of $296.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents soared 433.55% in 2023, then sank 59.7% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $395.2 million in 2022, then fell by 25.0% to $296.4 million in 2023, then retreated by 6.47% to $277.2 million in 2024, then climbed by 24.3% to $344.6 million in 2025, then retreated by 8.84% to $314.1 million in 2026.
• The last three Cash & Equivalents figures came in at $314.1 million (Q1 2026), $344.6 million (Q4 2025), and $299.2 million (Q3 2025), per Business Quant data.